Pharma Tech

AHA26: Semaglutide’s real-world CV benefits highlight importance of persistence

Nov 13, 2026, 4:07 PM

Read Full Article → AHA26: Semaglutide’s real-world CV benefits highlight importance of persistence

Translate article text

Choose a language and wait for the translated text.

Real-world semaglutide CV outcomes mirror clinical trials, with greater treatment persistence linked to better outcomes.